A Study of Modakafusp Alfa on Adult Participants With Relapsed/Refractory Multiple Myeloma
Clinical trial NCT03215030 · TERMINATED
Trial details
- NCT number
- NCT03215030
- Sponsor
- Teva Branded Pharmaceutical Products R&D LLC
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-04
- Primary completion
- 2024-07-01
- Enrollment
- 272
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.